Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Allyl chloroformate | HCID 18052 | — |
| Reactant | HCID 86737516 | HCID 86737516 | — |
| Reactant | 7-Bromo-6-chloroquinazolin-4(1H)-one | HCID 135711216 | — |
| Product | 17518-99-9 | HCID 20289806 | — |
Reaction Steps
The said known procedure comprises reacting trans 1-(3-methoxy-2-piperidyl)-2-propanone hydrobromide with hydrobromic acid as in U.S. Pat. No. 2,775,597 to form the trans 3-bromo-1-(3-methoxy-2-piperidyl)-2-propanone hydrobromide, reacting the latter with allyl chloroformate as indicated in J. Org. Chem., Vol. 20 (1955), p. 118-142 to block the nitrogen atom of the piperidine with allyloxycarbonyl by forming 1-allyloxycarbonyl-2-(ω-bromoacetonyl)-3-methoxypiperidine, condensing the latter with 6-chloro-7-bromo-3,4-dihydro-4-quinazolinone as described in French Pat. No. 1,550,956 to obtain 7-bromo-6-chloro-3-[3-(1-allyloxycarbonyl-3-methoxy-2-piperidyl)-acetonyl]-4(3H)-quinazolinone, subjecting the latter to hydrobromic acid as taught in French Pat. No. 1,550,956 to obtain 7-bromo-6-chloro-3-[3-(3-hydroxy-2-piperidyl)-acetonyl]-4(3H)-quinazolinone hydrobromide and treating the latter with a base to form the corresponding free base which if desired may be salified with a non-toxic, pharmaceutically acceptable acid to form the desired acid addition salt.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US04252947 |
|---|
| Source dataset | uspto-grants-1981_02 |
|---|
| ORD ID | ord-55ede120ef45492d8cb1a248d0f142a4 |
|---|
| Source note | uspto-grants-1981_02 |
|---|